Skip to content

DA32 Life Science Tech Acquisition Corp.

Delisted

CIK 1863294fmd_1BXEF4PANMXHAACC1ZB5Y2K14WFinance, Insurance and Real Estate · Blank ChecksTemplate: Standard

Coverage: Jan 01, 2021 to Mar 31, 2023, 8 periods

Latest annual · FY2022

Millions
Operating income
(2)
Net income
1

Latest quarter · Q1 FY2023

Millions
Operating income
(0)
Net income
1
Open Financials

DA32 Life Science Tech Acquisition Corp. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Operating income-$1.8 million10-K 2023-03-29 · proof
Net income$599,21510-K 2023-03-29 · proof
Cash from operating activities-$1.1 million10-K 2023-03-29 · proof
Total assets$203.9 million$202.5 million+0.7%10-K 2023-03-29 · proof
Total liabilities$6.7 million$5.9 million+13%10-K 2023-03-29 · proof
Cash and cash equivalents$699,256$1.9 million-62.5%10-K 2023-03-29 · proof
What was DA32 Life Science Tech Acquisition Corp.'s operating income in fiscal 2022?
DA32 Life Science Tech Acquisition Corp. reported operating income of -$1.8 million for fiscal 2022 (the year ended Dec 31, 2022). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
What was DA32 Life Science Tech Acquisition Corp.'s net income in fiscal 2022?
DA32 Life Science Tech Acquisition Corp. reported net income of $599,215 for fiscal 2022 (the year ended Dec 31, 2022). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
What was DA32 Life Science Tech Acquisition Corp.'s cash from operating activities in fiscal 2022?
DA32 Life Science Tech Acquisition Corp. reported cash from operating activities of -$1.1 million for fiscal 2022 (the year ended Dec 31, 2022). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
What are DA32 Life Science Tech Acquisition Corp.'s total assets?
As of Dec 31, 2022, DA32 Life Science Tech Acquisition Corp. reported total assets of $203.9 million, against $202.5 million a year earlier (+0.7%). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
What are DA32 Life Science Tech Acquisition Corp.'s total liabilities?
As of Dec 31, 2022, DA32 Life Science Tech Acquisition Corp. reported total liabilities of $6.7 million, against $5.9 million a year earlier (+13%). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC
What are DA32 Life Science Tech Acquisition Corp.'s cash and cash equivalents?
As of Dec 31, 2022, DA32 Life Science Tech Acquisition Corp. reported cash and cash equivalents of $699,256, against $1.9 million a year earlier (-62.5%). Source: the 10-K filed with the SEC on Mar 29, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1863294&period_type=annual&limit=5"

Information only, not investment advice.